Switch View
© Globe Newswire
27.10.2025
ISIN: KYG211081248
China Medical System Holdings Ltd
867
LISTED
HKSE
CMS (867.HK; 8A8.SG) Signed A Distribution Agreement for Ophthalmic Drugs Lucentis® and Beovu®
News Preview
SHENZHEN, CHINA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that on 27 October 2025, the Group through its subsidiary CMS VISION INTERNATIONAL MANAGEMENT LIMITED entered into a Distribution Agreement (the “Agreement”) with Novartis Pharma Services AG (“Novartis”) for Rani...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US70975L1070
Penumbra Inc
PEN
LISTED
NYSE
Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism
News Preview
ALAMEDA, Calif., Oct. 27, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) announced the results of the landmark STORM-PE randomized controlled trial (RCT), which found that the use of mechanical thrombectomy, specifically computer assisted vacuum thrombectomy (CAVT™), with anticoagulation achieved superior reduct...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before November 10, 2025 to Discuss Your Rights - LNTH
News Preview
NEW YORK, Oct. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH).
Shareholders wh...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
27.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in Baxter International, Inc. Lawsuit - BAX
News Preview
NEW YORK, Oct. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. (NYSE: BAX).
Shareholders wh...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
27.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Lost Money on Savara Inc.(SVRA)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
News Preview
NEW YORK, Oct. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA).
Shareholders who purchased...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics, Incorporated Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before November 17, 2025 to Discuss Your Rights - CYTK
News Preview
NEW YORK, Oct. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK).
Shareholders...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US1897631057
Co-Diagnostics Inc
CODX
LISTED
NASDAQ
Co-Diagnostics Signs Definitive Agreement with Arabian Eagle in the Kingdom of Saudi Arabia to Establish CoMira Diagnostics and Localize Co-Dx™ PCR Platform Across the Middle East
News Preview
The new Saudi-based CoMira Diagnostics joint venture will be engaged in manufacturing and distribution of the Company's upcoming Co-Dx™ PCR platform and other Co-Dx IP across KSA and 18 other MENA countries
SALT LAKE CITY,...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Class Action Filed Against LifeMD, Inc. (LFMD) Seeking Recovery for Investors - Contact The Gross Law Firm
News Preview
NEW YORK, Oct. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD).
Shareholders who purchased...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
The Gross Law Firm Notifies Semler Scientific, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SMLR
News Preview
NEW YORK, Oct. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR).
Shareholders wh...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
Shareholders that lost money on MoonLake Immunotherapeutics(MLTX) should contact The Gross Law Firm about pending Class Action - MLTX
News Preview
NEW YORK, Oct. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of MoonLake Immunotherapeutics (NASDAQ: MLTX).
Shareholder...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US64132R4048
MetaVia Inc
NRBO
LISTED
NASDAQ
MetaVia Announces Poster Presentation on Vanoglipel (DA-1241) at the AASLD Liver Meeting
News Preview
CAMBRIDGE, Mass., Oct. 27, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting data on Vanoglipel (DA-1241), a novel G-Protein-Coupled Receptor 119 (GPR119) agonist, has been accept...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MOONLAKE IMMUNOTHERAPEUTICS SECURITIES FRAUD NOTICE: Berger Montague Informs MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors of Securities Fraud Lawsuit
News Preview
PHILADELPHIA, Oct. 27, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against MoonLake Immunotherapeutics (NASDAQ: MLTX) ("MoonLake" or the "Company") on behalf of investors who purchased MoonLake shares during the period of March 10, 2024 through September...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
27.10.2025
ISIN: US40412C1018
HCA Healthcare Inc
HCA
LISTED
NYSE
HCA Announces Proposed Public Offering of Senior Notes
News Preview
HCA Healthcare, Inc. (NYSE: HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior notes, including maturity, interest rate and principal amount, will depend on market conditions at the time of pricing. HCA Inc. intends to use the net p...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US45773H4092
Inovio Pharmaceuticals Inc
INO
LISTED
NASDAQ
INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025
News Preview
PLYMOUTH MEETING, Pa., Oct. 27, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancers, and infectious diseases, today announced that its third quarter 2025 financial results w...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US40131M1099
Guardant Health Inc
GH
LISTED
NASDAQ
Guardant Health and Zephyr AI Announce Partnership to Unlock Drug Response Predictions and Biomarker Insights
News Preview
Guardant Health (Nasdaq: GH), a leading precision oncology company, and Zephyr AI, a leader in precision medicine harnessing artificial intelligence to accelerate drug development, today announced a strategic partnership to deliver novel, scalable, and actionable insights that support biopharmaceutical innovation. This collaboration will combine u...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US1241551027
Butterfly Network Inc
BFLY
LISTED
NYSE
Butterfly Network Strengthens Global Information Security Posture with ISO 27001, SOC-2 Type 2, C5 Germany, and NHS DSPT Accreditations
News Preview
Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced it has achieved certification for ISO 27001, the world’s leading standard for information security management systems, published by the International Organization for Standardization (I...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
New study reveals substantial unmet need in psoriasis, shows strong patient and provider preference for highly effective oral treatments with favorable safety profile
News Preview
Findings highlight opportunity for shared decision-making to improve treatment planning, with more than 90% of patients currently on injectables willing to switch to a new oral therapy with equivalent efficacy and a favorable safety profile
Results show 50.5% of...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US81663L2007
GeneDx Holdings Corp
WGS
LISTED
NASDAQ
GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims
News Preview
SAN FRANCISCO, Oct. 27, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP reminds GeneDx Holdings Corp. (NASDAQ: WGS) investors that the firm is investigating potential legal claims relating to whether the company misled investors about its health intelligence platform called Centrellis. Current shareholder...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US68572M1062
Orchestra Biomed Holdings Inc
OBIO
LISTED
NASDAQ
Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial
News Preview
NEW HOPE, Pa., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, today announced the first patient enrollments in the Virtue...
Themefolio
Profiler
Peergroup
© Newsfile
27.10.2025
ISIN: US29415V1098
Envoy Medical, Inc.
COCH
LISTED
NASDAQ
Envoy Medical Receives Positive Listing Determination from NASDAQ
News Preview
White Bear Lake, Minnesota--(Newsfile Corp. - October 27, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that the Nasdaq Hearings Panel (the "Panel) has granted the Company's request for continued listing on the Nasdaq Stock Market...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US04963C2098
AtriCure Inc
ATRC
LISTED
NASDAQ
AtriCure to Participate in Upcoming Investor Conferences
News Preview
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in upcoming investor conferences.
AtriCure’s management is scheduled to participate in a firesid...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US3741631036
Geron Corp
GERN
LISTED
NASDAQ
Geron Plans to Announce Third Quarter 2025 Financial Results on November 5, 2025
News Preview
Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company aiming to change lives by changing the course of cancer, today announced that it will release its third quarter financial results and business highlights before the market opens on Wednesday, November 5, 2025 via press release, which will be available on the Company’s w...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon
News Preview
STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) announced that, in light of ongoing discussions with Alcon (SIX/NYSE: ALC), STAAR’s Special Meeting of Stockholders in connection with STAAR’s merger agreement with Alcon (the “Special Meeting”), which was previously adjourned until November 6, 2025 at...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: GB00BD3VFW73
ConvaTec Group PLC
CTEC
LISTED
LSE
Stigma, Not Condition, Is the Biggest Barrier for 1 in 3 People Living With Chronic Conditions, According to New Convatec Research
News Preview
Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today announced the publication of a new report revealing that millions of people feel they need to hide their health conditions in plain sight. Perspectives on living with chronic conditions – research undertaken in the Uni...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: GB00BD3VFW73
ConvaTec Group PLC
CTEC
LISTED
LSE
Stigma, Not Condition, Is the Biggest Barrier for 1 in 3 People Living With Chronic Conditions, According to New Convatec Research
News Preview
Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today announced the publication of a new report revealing that millions of people feel they need to hide their health conditions in plain sight. Perspectives on living with chronic conditions – research undertaken in the Uni...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US74834L1008
Quest Diagnostics Inc
DGX
LISTED
NYSE
New Study Demonstrates Accuracy of Two Quest AD-Detect® Tests for Alzheimer's Disease Diagnosis
News Preview
The Quest AD-Detect® blood-based test panels deliver confirmatory accuracy, potentially supporting reduced reliance on PET-imaging confirmation
SECAUCUS, N.J., Oct. 27, 2025 /PRNewswire/ -- Two blood tests, each involving multiple biomarkers, are highly accurate...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX INVESTOR NOTICE: MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
News Preview
SAN DIEGO, Oct. 27, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that the MoonLake class action lawsuit – captioned Peters v. MoonLake Immunotherapeutics, No. 25-cv-08612, and pending in the Southern District of New York – seeks to represent purchasers or acquirers of MoonLake Immunotherape...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US2560861096
DocGo Inc
DCGO
LISTED
NASDAQ
DocGo to Announce Third Quarter 2025 Results on Monday, November 10, 2025
News Preview
DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that the Company will release its financial results for the third quarter ended September 30, 2025 after the markets close on Monday, November 10, 2025. Management will also host a confer...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Icotrokinra maintains standout combination of therapeutic benefit and a favorable safety profile in once-daily pill through 28 weeks in ulcerative colitis
News Preview
Building on 12-week findings, icotrokinra demonstrated clinically meaningful outcomes at Week 28 with 31.7% of patients achieving clinical remission and 38.1% showing endoscopic improvement versus placebo in the Phase 2b ANTHEM-UC study
Results support Phase 3 c...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
TREMFYA® (guselkumab), the first and only IL-23 inhibitor with a fully subcutaneous treatment regimen, demonstrates durable remission in Crohn's disease at two years
News Preview
Clinical remission rates were over 85% for both TREMFYA® maintenance doses at 96 weeks in both the Phase 3 GRAVITI and GALAXI studies
TREMFYA® is the only IL-23 inhibitor to demonstrate durable endoscopic and clinical remission with a fully subcutaneous regimen...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US53635D2027
Liquidia Corp
LQDA
LISTED
NASDAQ
Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025
News Preview
MORRISVILLE, N.C., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its third quarter 2025 financial results on Monday, November 3, 2025. The company will host a webcast at 8:30 a.m....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US68622P1093
Oric Pharmaceuticals Inc
ORIC
LISTED
NASDAQ
ORIC® Pharmaceuticals Presented Preclinical Data at the EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics Supporting Best-in-Class Potential of ORIC-944 to Treat Patients With Prostate Cancer and Other Solid Tumors
News Preview
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, presented posters at the 2025 EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeu...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US68622V1061
Organon & Co
OGN
LISTED
NYSE
Organon Appoints Company Executive Joseph Morrissey as Interim CEO and Board Chair Carrie Cox as Executive Chair; Announces Results of Audit Committee Investigation
News Preview
Organon (NYSE: OGN) (“Organon” or “the company”) today announced that its Board of Directors has appointed the Company’s Executive Vice President and Head of Manufacturing & Supply, Joseph Morrissey, Interim Chief Executive Officer. Board Chair Carrie S. Cox will also take on additional responsibilities on an interim basis as Executive Chair t...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US45337C1027
Incyte Corp
INCY
LISTED
NASDAQ
Incyte and Enable Injections Announce Strategic Partnership for enFuse® On-Body Delivery System
News Preview
Incyte (NASDAQ:INCY) and Enable Injections, Inc. (“Enable”) today announced a new partnership to develop and commercialize specific assets in Incyte’s portfolio, including its investigational, first-in-class mutant calreticulin (mutCALR) selective monoclonal antibody, with Enable’s enFuse® On-Body Delivery System.
This press release features mult...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: CH0499880968
ADC Therapeutics SA
ADCT
LISTED
NYSE
ADC Therapeutics to Present at November Investor Conferences
News Preview
LAUSANNE, Switzerland, Oct. 27, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced participation in three upcoming investor conferences in November:...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US14167L1035
CareDx Inc
CDNA
LISTED
NASDAQ
CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer
News Preview
CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the appointment of Jeffrey John Teuteberg, MD, as Chief Medical Officer, eff...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US03837C1062
Apyx Medical Corp
APYX
LISTED
NASDAQ
Apyx Medical Corporation to Participate in Upcoming November Investor Conferences
News Preview
CLEARWATER, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body Contouring System™, today announced that Charles Goodwin, President and CEO and Matt Hill, CFO wi...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US03168L1052
Amneal Pharmaceuticals Inc
AMRX
LISTED
NASDAQ
Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches
News Preview
BRIDGEWATER, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced the U.S. commercial launch of Brekiya® (dihydroergotamine mesylate) injection, the first and only ready-to-use dihydroergotamine (DHE) autoinjector approved for the acute treatment of migraine with or withou...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US00091E1091
Absci Corp
ABSI
LISTED
NASDAQ
Absci to Participate in Upcoming Investor Conferences
News Preview
VANCOUVER, Wash. and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biotech company advancing breakthrough therapeutics with generative AI, today announced the company will be participating in the following upcoming investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US29664W1053
Esperion Therapeutics Inc
ESPR
LISTED
NASDAQ
Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025
News Preview
ANN ARBOR, Mich., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that an oral presentation and a poster presentation have been accepted for presentation at the AHA Scientific Sessions 2025 in New Orleans, LA, November 7-10, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Healthcare Conference
News Preview
MINNEAPOLIS, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 2025 UBS Global Healt...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US6951271005
Pacira Biosciences Inc
PCRX
LISTED
NASDAQ
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL®
News Preview
BRISBANE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients today reported it has received a Paragraph IV Certification Notice Letter (PIV Notice) from Qilu Pharmaceutical (Hainan) Co., Ltd., a...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US30063P1057
Exact Sciences Corp
EXAS
LISTED
NASDAQ
Exact Sciences Presents New Findings at ACG 2025 Demonstrating How the Cologuard Test Helps Improve Adherence and Close Screening Gaps
News Preview
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced new data being presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting, taking place October 24–29, 2025, at the Phoenix Convention Center in Phoenix, Arizona. The company’s research showcases leadership i...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US4622221004
Ionis Pharmaceuticals Inc
IONS
LISTED
NASDAQ
Detailed data from the landmark CORE and CORE2 pivotal studies of olezarsen for sHTG to be presented as a late breaker at AHA Scientific Sessions
News Preview
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that detailed data from the landmark pivotal Phase 3 CORE and CORE2 studies of olezarsen in people with severe hypertriglyceridemia (sHTG) will be presented during a late-breaking session, titled “Groundbreaking Trials in Cardiometabolic Therapeutics”, at the American Heart Association (AH...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US00653Q1022
Adapthealth Corp
AHCO
LISTED
NASDAQ
Halper Sadeh LLC Encourages AdaptHealth Corp. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of AdaptHealth Corp. (NASDAQ: AHCO) breached their fiduciary duties to shareholders.
If you currently own AdaptHealth stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the c...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US1101221083
Bristol-Myers Squibb Co
BMY
LISTED
NYSE
Bristol Myers Squibb Presents Two Late-Breaking Presentations Demonstrating Sotyktu (deucravacitinib) Efficacy in Psoriatic Arthritis and Systemic Lupus Erythematosus
News Preview
Bristol Myers Squibb (NYSE:BMY) today announced Week 52 data from the pivotal Phase 3 POETYK PsA-1 trial further confirming the efficacy and safety of Sotyktu (deucravacitinib) in adults with active psoriatic arthritis (PsA) who were not previously treated with a biologic disease-modifying antirheumatic drug (bDMARD). The company also announced ne...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
U.S. FDA Approves Updated Indication for WINREVAIR™ (sotatercept-csrk) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension) Based on Phase 3 ZENITH Study
News Preview
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an update to the U.S. product label based on the Phase 3 ZENITH trial for WINREVAIR™ (sotatercept-csrk) for injection, 45mg, 60mg. WINREVAIR, an activin signaling inhibitor, is now FDA-approved for the...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US00653Q1022
Adapthealth Corp
AHCO
LISTED
NASDAQ
Halper Sadeh LLC Encourages AdaptHealth Corp. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of AdaptHealth Corp. (NASDAQ: AHCO) breached their fiduciary duties to shareholders.
If you currently own AdaptHealth stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the c...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US45826J1051
Intellia Therapeutics Inc
NTLA
LISTED
NASDAQ
Intellia Therapeutics Provides Update on MAGNITUDE Clinical Trials of Nexiguran Ziclumeran (nex-z)
News Preview
Conference call today at 8:30 a.m. ET Conference call today at 8:30 a.m. ET...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US4884452065
Zevra Therapeutics Inc
ZVRA
LISTED
NASDAQ
Zevra Therapeutics Announces Details for Q3 2025 Financial Results Call
News Preview
- Company will host conference call at 4:30 p.m. ET on Wednesday, November 5, 2025 - Company will host conference call at 4:30 p.m. ET on Wednesday, November 5, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US28414H1032
Elanco Animal Health Inc
ELAN
LISTED
NYSE
Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species
News Preview
FDA approves expanded Credelio Quattro and Credelio labels to include prevention of Lyme disease as a result of killing black-legged ticks (lxodes scapularis) and protection against the longhorned tick (Haemaphysalis longicornis), which is rapidly spreading, now reaching 22 states.i
The Compan...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US6323071042
Natera Inc
NTRA
LISTED
NASDAQ
Halper Sadeh LLC Encourages Natera Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Natera Inc. (NASDAQ: NTRA) breached their fiduciary duties to shareholders.
If you currently own Natera stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a c...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US1255091092
Cigna Group (The)
CI
LISTED
NYSE
Evernorth Announces New Era of Pharmacy Benefit Services to Lower Americans' Medication Costs
News Preview
Unveils Transparent Rebate-Free Pharmacy Benefit; Lower Costs and Better Experience for Americans; Greater Support for Local Pharmacies
BLOOMFIELD, Conn., Oct. 27, 2025 /PRNewswire/ -- Evernorth, the health services division of The Cigna Group (NYSE:CI) today an...
Themefolio
Profiler
Peergroup
© EQS Newswire
27.10.2025
ISIN: CH0039821084
Metall Zug AG
METN
LISTED
SIX
Financing for further development of Tech Cluster Zug (TCZ)
News Preview
Metall Zug AG
/ Key word(s): Financing
Metall Zug: Financing for further development of Tech Cluster Zug (TCZ)
27.10.2025 / 11:14 CET/CEST
Media announcement
Zug, October 27, 2025 – Metall Zug (SIX: METN) has concluded financing for the further development of the Tech Cluster Zug (TCZ) through a syndicated loan
Syndic......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.10.2025
ISIN: CH0039821084
Metall Zug AG
METN
LISTED
SIX
Finanzierung für die Weiterentwicklung des Tech Cluster Zug (TCZ)
News Preview
Metall Zug AG
/ Schlagwort(e): Finanzierung
Metall Zug: Finanzierung für die Weiterentwicklung des Tech Cluster Zug (TCZ)
27.10.2025 / 11:14 CET/CEST
Medienmitteilung
Zug, 27. Oktober 2025 – Metall Zug (SIX: METN) hat die Finanzierung für die Weiterentwicklung des Technologiecluster Zug (TCZ) über einen Konsortialkredit......
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US98937L1052
Zenas BioPharma, Inc.
ZBIO
LISTED
NASDAQ
Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis
News Preview
- Obexelimab met primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo, p=0.0009 -...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US9553061055
West Pharmaceutical Services Inc
WST
LISTED
NYSE
West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery
News Preview
EXTON, Pa., Oct. 27, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the launch of its West Synchrony™ Prefillable Syringe (PFS) System at CPHI Worldwide in Frankfurt, Germany. This innovative system m...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: KYG8807B1068
Theravance Biopharma Inc
TBPH
LISTED
NASDAQ
Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025
News Preview
DUBLIN, Oct. 27, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its third quarter 2025 financial results and provide a business update after market close on Monday, November 10, 2025. An accompanying conference call and simultaneous webcast will be hosted at 5:00 pm EST (2:00 pm PST /...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US4158581094
Harrow Inc
HROW
LISTED
NASDAQ
Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025
News Preview
Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on November 11, 2025 Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on November 11, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US5015751044
Kymera Therapeutics Inc
KYMR
LISTED
NASDAQ
Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting
News Preview
KT-579, a potent, selective, oral degrader of IRF5, demonstrated broad activity across multiple preclinical models of lupus and rheumatoid arthritis (RA), with activity comparable or superior to approved and clinically active therapies...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
